Redmond Asset Management LLC Acquires 887 Shares of CME Group Inc. (NASDAQ:CME)

Redmond Asset Management LLC increased its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 6.9% in the fourth quarter, Holdings Channel reports. The institutional investor owned 13,765 shares of the financial services provider’s stock after buying an additional 887 shares during the period. Redmond Asset Management LLC’s holdings in CME Group were worth $3,197,000 at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Truvestments Capital LLC acquired a new stake in CME Group during the third quarter worth about $26,000. SJS Investment Consulting Inc. lifted its holdings in shares of CME Group by 570.6% in the fourth quarter. SJS Investment Consulting Inc. now owns 114 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 97 shares during the last quarter. Dunhill Financial LLC boosted its stake in shares of CME Group by 188.4% in the 3rd quarter. Dunhill Financial LLC now owns 124 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 81 shares in the last quarter. Financial Life Planners bought a new stake in shares of CME Group during the 4th quarter valued at approximately $32,000. Finally, Fortitude Family Office LLC grew its holdings in shares of CME Group by 120.3% during the 4th quarter. Fortitude Family Office LLC now owns 152 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 83 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors.

Insider Buying and Selling at CME Group

In other CME Group news, insider Julie Winkler sold 11,592 shares of the company’s stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now owns 21,885 shares in the company, valued at approximately $5,453,085.45. This represents a 34.63 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.30% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on the stock. Oppenheimer raised their target price on shares of CME Group from $258.00 to $269.00 and gave the company an “outperform” rating in a research report on Thursday, February 13th. Keefe, Bruyette & Woods boosted their price objective on CME Group from $256.00 to $257.00 and gave the stock a “market perform” rating in a research report on Friday, February 14th. Piper Sandler increased their target price on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft cut their price target on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Finally, Barclays upped their price target on shares of CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research report on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, eight have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $236.13.

Read Our Latest Stock Analysis on CME

CME Group Stock Up 0.2 %

CME Group stock opened at $248.88 on Friday. The company has a market capitalization of $89.69 billion, a PE ratio of 25.74, a PEG ratio of 6.83 and a beta of 0.57. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $253.53. The firm’s fifty day moving average is $237.10 and its 200 day moving average is $227.36. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 earnings per share for the quarter, beating the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. As a group, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group announced that its board has authorized a share buyback program on Thursday, December 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to buy up to 3.4% of its stock through open market purchases. Stock repurchase programs are generally a sign that the company’s board of directors believes its stock is undervalued.

CME Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be issued a $1.25 dividend. The ex-dividend date of this dividend is Friday, March 7th. This represents a $5.00 annualized dividend and a yield of 2.01%. This is a positive change from CME Group’s previous quarterly dividend of $1.15. CME Group’s dividend payout ratio is presently 47.57%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.